254 related articles for article (PubMed ID: 31127561)
1. Application of Stable Isotope Labels for Metabolomics in Studies in Fatty Liver Disease.
Puchalska P; Crawford PA
Methods Mol Biol; 2019; 1996():259-272. PubMed ID: 31127561
[TBL] [Abstract][Full Text] [Related]
2. Stable Isotope Tracers for Metabolic Pathway Analysis.
Violante S; Berisa M; Thomas TH; Cross JR
Methods Mol Biol; 2019; 1978():269-283. PubMed ID: 31119669
[TBL] [Abstract][Full Text] [Related]
3. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
[TBL] [Abstract][Full Text] [Related]
4. Amino Acid Metabolism is Altered in Adolescents with Nonalcoholic Fatty Liver Disease-An Untargeted, High Resolution Metabolomics Study.
Jin R; Banton S; Tran VT; Konomi JV; Li S; Jones DP; Vos MB
J Pediatr; 2016 May; 172():14-19.e5. PubMed ID: 26858195
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics profiling of steatosis progression in HepaRG
Cuykx M; Claes L; Rodrigues RM; Vanhaecke T; Covaci A
Toxicol Lett; 2018 Apr; 286():22-30. PubMed ID: 29355688
[TBL] [Abstract][Full Text] [Related]
6. A Protocol to Compare Methods for Untargeted Metabolomics.
Wang L; Naser FJ; Spalding JL; Patti GJ
Methods Mol Biol; 2019; 1862():1-15. PubMed ID: 30315456
[TBL] [Abstract][Full Text] [Related]
7. Chloroformate derivatization for tracing the fate of Amino acids in cells and tissues by multiple stable isotope resolved metabolomics (mSIRM).
Yang Y; Fan TW; Lane AN; Higashi RM
Anal Chim Acta; 2017 Jul; 976():63-73. PubMed ID: 28576319
[TBL] [Abstract][Full Text] [Related]
8. Stable isotope-assisted metabolomics for network-wide metabolic pathway elucidation.
Creek DJ; Chokkathukalam A; Jankevics A; Burgess KE; Breitling R; Barrett MP
Anal Chem; 2012 Oct; 84(20):8442-7. PubMed ID: 22946681
[TBL] [Abstract][Full Text] [Related]
9. X13CMS: global tracking of isotopic labels in untargeted metabolomics.
Huang X; Chen YJ; Cho K; Nikolskiy I; Crawford PA; Patti GJ
Anal Chem; 2014 Feb; 86(3):1632-9. PubMed ID: 24397582
[TBL] [Abstract][Full Text] [Related]
10. geoRge: A Computational Tool To Detect the Presence of Stable Isotope Labeling in LC/MS-Based Untargeted Metabolomics.
Capellades J; Navarro M; Samino S; Garcia-Ramirez M; Hernandez C; Simo R; Vinaixa M; Yanes O
Anal Chem; 2016 Jan; 88(1):621-8. PubMed ID: 26639619
[TBL] [Abstract][Full Text] [Related]
11. Stable Isotope-Resolved Metabolomics by NMR.
Lin P; Lane AN; Fan TW
Methods Mol Biol; 2019; 2037():151-168. PubMed ID: 31463844
[TBL] [Abstract][Full Text] [Related]
12. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
[TBL] [Abstract][Full Text] [Related]
13. Natural isotope correction of MS/MS measurements for metabolomics and (13)C fluxomics.
Niedenführ S; ten Pierick A; van Dam PT; Suarez-Mendez CA; Nöh K; Wahl SA
Biotechnol Bioeng; 2016 May; 113(5):1137-47. PubMed ID: 26479486
[TBL] [Abstract][Full Text] [Related]
14. Development of pseudo-targeted profiling of isotopic metabolomics using combined platform of high resolution mass spectrometry and triple quadrupole mass spectrometry with application of
Wang X; Luo C; Xu L; Wang Y; Guo LJ; Jiao Y; Deng H; Liu X
J Chromatogr A; 2023 May; 1696():463923. PubMed ID: 37023637
[TBL] [Abstract][Full Text] [Related]
15. Stable isotope-based flux studies in nonalcoholic fatty liver disease.
McCullough A; Previs S; Kasumov T
Pharmacol Ther; 2018 Jan; 181():22-33. PubMed ID: 28720429
[TBL] [Abstract][Full Text] [Related]
16. In-vivo tracking of deuterium metabolism in mouse organs using LC-MS/MS.
Kasarla SS; Flocke V; Saw NMT; Fecke A; Sickmann A; Gunzer M; Flögel U; Phapale P
J Chromatogr A; 2024 Feb; 1717():464691. PubMed ID: 38301333
[TBL] [Abstract][Full Text] [Related]
17. TARDIS-based microbial metabolomics: time and relative differences in systems.
Winder CL; Dunn WB; Goodacre R
Trends Microbiol; 2011 Jul; 19(7):315-22. PubMed ID: 21664817
[TBL] [Abstract][Full Text] [Related]
18. Untargeted metabolomics reveals the role of AQP9 in nonalcoholic fatty liver disease in a mice model.
Cheng Q; Zhang J; Fang J; Ding H; Xu Y; Lu X; Zhang W
Int J Biol Macromol; 2022 Oct; 219():864-875. PubMed ID: 35961555
[TBL] [Abstract][Full Text] [Related]
19. Stable Isotope-Labeled Lipidomics to Unravel the Heterogeneous Development Lipotoxicity.
Shih LM; Tang HY; Lynn KS; Huang CY; Ho HY; Cheng ML
Molecules; 2018 Nov; 23(11):. PubMed ID: 30400243
[TBL] [Abstract][Full Text] [Related]
20. Stable isotope labeling strategy for curcumin metabolite study in human liver microsomes by liquid chromatography-tandem mass spectrometry.
Gao D; Chen X; Yang X; Wu Q; Jin F; Wen H; Jiang Y; Liu H
J Am Soc Mass Spectrom; 2015 Apr; 26(4):686-94. PubMed ID: 25592681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
